Susan L. Lindquist Massachusetts Non-exempt Marital Trust - Net Worth and Insider Trading

Susan L. Lindquist Massachusetts Non-exempt Marital Trust Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Susan L. Lindquist Massachusetts Non-exempt Marital Trust owns 2 companies in total, including Yumanity Therapeutics Inc (YMTX) , and Kineta Inc (KA) .

Click here to see the complete history of Susan L. Lindquist Massachusetts Non-exempt Marital Trust’s form 4 insider trades.

Insider Ownership Summary of Susan L. Lindquist Massachusetts Non-exempt Marital Trust

Ticker	Comapny	Transaction Date	Type of Owner
YMTX	Yumanity Therapeutics Inc	2020-12-22	10 percent owner
KA	Kineta Inc	2020-12-22	10 percent owner

Susan L. Lindquist Massachusetts Non-exempt Marital Trust Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Susan L. Lindquist Massachusetts Non-exempt Marital Trust Ownership Network

Ownership Network List of Susan L. Lindquist Massachusetts Non-exempt Marital Trust

No Data

Ownership Network Relation of Susan L. Lindquist Massachusetts Non-exempt Marital Trust

Susan L. Lindquist Massachusetts Non-exempt Marital Trust Owned Company Details

What does Yumanity Therapeutics Inc do?

Who are the key executives at Yumanity Therapeutics Inc?

Susan L. Lindquist Massachusetts Non-exempt Marital Trust is the 10 percent owner of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Scientific Officer Thierry Guillaudeux , and Chief Financial Officer Keith Baker .

Yumanity Therapeutics Inc (YMTX) Insider Trades Summary

Over the past 18 months, Susan L. Lindquist Massachusetts Non-exempt Marital Trust made no insider transaction in Yumanity Therapeutics Inc (YMTX). Other recent insider transactions involving Yumanity Therapeutics Inc (YMTX) include a net sale of 10,890 shares made by Richard Peters , a net sale of 3,116 shares made by Michael D Wyzga , and a net sale of 3,116 shares made by Devin Whittemore Smith .

In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,098 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 19,098 shares.

Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Yumanity Therapeutics Inc Insider Transactions

No Available Data

Susan L. Lindquist Massachusetts Non-exempt Marital Trust Mailing Address

Above is the net worth, insider trading, and ownership report for Susan L. Lindquist Massachusetts Non-exempt Marital Trust. You might contact Susan L. Lindquist Massachusetts Non-exempt Marital Trust via mailing address: C/o Nancy Dempze, Hemenway & Barnes, Llp, 75 State Street, Boston Ma 02109.

Discussions on Susan L. Lindquist Massachusetts Non-exempt Marital Trust

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.